Department of Pharmaceutical Services, Oslo Hospital Pharmacy, Hospital Pharmacies Enterprise, South Eastern Norway, Oslo, Norway.
General Internal Medicine Ward, the Medical Clinic, Oslo University Hospital, Oslo, Norway.
PLoS One. 2019 Jul 22;14(7):e0220071. doi: 10.1371/journal.pone.0220071. eCollection 2019.
Knowledge of risk factors for drug-related hospitalizations (DRHs) is limited.
To examine the prevalence of DRHs and the relationships between DRHs and various variables in multimorbid patients admitted to an internal medicine ward.
Multimorbid patients ≥ 18 years, using minimum of four regular drugs from minimum two therapeutic classes, were included from the Internal Medicine ward, Oslo University Hospital, Norway, from August 2014 to March 2016. Clinical pharmacists prospectively conducted medicines reconciliations and reviews to reveal drug-related problems (DRPs). Blinded for identified DRPs, an interdisciplinary group retrospectively made comprehensive, clinical assessments of each patient case to classify hospitalizations as drug-related (DRH) or non-drug-related (non-DRH). Age, sex distribution, Charlson Comorbidity Index (CCI), renal function, aberrant genotype frequencies, body-mass index, number of drugs, proportion of patients which received assistance for drug administration from the home care service, and/or through multidose-dispensed drugs, and occurrence of specific DRP subgroups, were compared separately between patients with DRHs versus non-DRHs, followed by multiple logistic regression analysis.
Hospitalizations were classified as drug-related in 155 of the 404 included patients (38%). Factors significantly associated with DRHs were occurrence of adverse effect DRPs (adjusted odds ratio (OR) 3.3, 95% confidence interval (CI) 1.4-8.0), adherence issues (OR 2.9, 1.1-7.2), home care (OR 1.9, 1.1-3.5), drug monitoring DRPs (OR 1.9, 1.2-3.0), and CCI score ≥6 (OR 0.33, 0.14-0.77). Frequencies of aberrant genotypes did not differ between the patient groups, but in 41 patients with DRHs (26.5%), gene-drug interactions influenced the assessments of DRHs.
DRHs are prevalent in multimorbid patients with adverse effect DRPs and adherence issues as the most important risk factors.
药物相关住院(DRH)的风险因素知之甚少。
研究多系统疾病患者中 DRH 的发生率及与各种变量的关系,这些患者被收入内科病房。
从挪威奥斯陆大学医院内科病房,选取 2014 年 8 月至 2016 年 3 月期间,年龄≥18 岁、至少使用四种来自至少两种治疗类别的常规药物的多系统疾病患者。临床药师前瞻性地进行药物重整和审查,以发现药物相关问题(DRP)。在对确定的 DRP 不知情的情况下,一个多学科小组对每个患者病例进行全面的临床评估,将住院分类为药物相关(DRH)或非药物相关(非-DRH)。比较 DRH 与非-DRH 患者之间的年龄、性别分布、Charlson 合并症指数(CCI)、肾功能、异常基因型频率、体重指数、药物数量、接受家庭护理服务药物管理帮助的患者比例、以及/或通过多剂量配药的药物,以及特定 DRP 亚组的发生情况,然后进行多因素逻辑回归分析。
404 例纳入患者中,有 155 例(38%)的住院被分类为药物相关。与 DRHs 显著相关的因素是发生不良反应 DRP(调整后的优势比(OR)3.3,95%置信区间(CI)1.4-8.0)、药物依从性问题(OR 2.9,1.1-7.2)、家庭护理(OR 1.9,1.1-3.5)、药物监测 DRP(OR 1.9,1.2-3.0)和 CCI 评分≥6(OR 0.33,0.14-0.77)。两组患者的异常基因型频率无差异,但在 41 例 DRH 患者(26.5%)中,基因-药物相互作用影响了 DRH 的评估。
多系统疾病患者中 DRH 很常见,其中不良反应 DRP 和药物依从性问题是最重要的危险因素。